ahlam1399
09-02-2015, 02:50 AM
UPDATE 1-Amgen?s bone drug succeeds in late-stage study
Sept 1 (Reuters) - Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study.
http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2.img (http://da.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/ach.htm)http://pi.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/497cb54d/sc/21/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=jpbcLFMdMcQ:g-0a1jJ5ThQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=jpbcLFMdMcQ:g-0a1jJ5ThQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=jpbcLFMdMcQ:g-0a1jJ5ThQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=jpbcLFMdMcQ:g-0a1jJ5ThQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=jpbcLFMdMcQ:g-0a1jJ5ThQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/jpbcLFMdMcQ
Sept 1 (Reuters) - Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study.
http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2.img (http://da.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/ach.img (http://adchoice.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/ach.htm)http://pi.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238385055512/u/49/f/654213/c/35217/s/497cb54d/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/497cb54d/sc/21/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=jpbcLFMdMcQ:g-0a1jJ5ThQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=jpbcLFMdMcQ:g-0a1jJ5ThQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=jpbcLFMdMcQ:g-0a1jJ5ThQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=jpbcLFMdMcQ:g-0a1jJ5ThQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=jpbcLFMdMcQ:g-0a1jJ5ThQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/jpbcLFMdMcQ